Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M606437200 on September 27, 2006

J. Biol. Chem., Vol. 281, Issue 50, 38535-38542, December 15, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/50/38535    most recent
M606437200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Höpner, S.
Right arrow Articles by Rötzschke, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Höpner, S.
Right arrow Articles by Rötzschke, O.
Related Collections
Right arrow Papers Of The Week
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Small Organic Compounds Enhance Antigen Loading of Class II Major Histocompatibility Complex Proteins by Targeting the Polymorphic P1 Pocket*{diamondsuit}

Sabine Höpner{ddagger}1, Katharina Dickhaut{ddagger}**, Maria Hofstätter{ddagger}, Heiko Krämer{ddagger}, Dominik Rückerl{ddagger}, J. Arvid Söderhäll§, Shashank Gupta{ddagger}2, Viviana Marin-Esteban{ddagger}, Ronald Kühne§3, Christian Freund§3, Günther Jung||3, Kirsten Falk{ddagger}34, and Olaf Rötzschke{ddagger}35

From the {ddagger}Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Strasse 10, D-13125 Berlin, Germany, the §Forschungsinstitut for Molecular Pharmacology (FMP), Robert-Rössle-Strasse 10, D-13125 Berlin, Germany, the Freie Universität Berlin, Thielallee 63, D-14195 Berlin, Germany, the ||Eberhard-Karls University, Auf der Morgenstelle 18, D-72076 Tübingen, Germany, and the **Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany

Major histocompatibility complex (MHC) molecules are a key element of the cellular immune response. Encoded by the MHC they are a family of highly polymorphic peptide receptors presenting peptide antigens for the surveillance by T cells. We have shown that certain organic compounds can amplify immune responses by catalyzing the peptide loading of human class II MHC molecules HLA-DR. Here we show now that they achieve this by interacting with a defined binding site of the HLA-DR peptide receptor. Screening of a compound library revealed a set of adamantane derivatives that strongly accelerated the peptide loading rate. The effect was evident only for an allelic subset and strictly correlated with the presence of glycine at the dimorphic position beta86 of the HLA-DR molecule. The residue forms the floor of the conserved pocket P1, located in the peptide binding site of MHC molecule. Apparently, transient occupation of this pocket by the organic compound stabilizes the peptide-receptive conformation permitting rapid antigen loading. This interaction appeared restricted to the larger Glybeta86 pocket and allowed striking enhancements of T cell responses for antigens presented by these "adamantyl-susceptible" MHC molecules. As catalysts of antigen loading, compounds targeting P1 may be useful molecular tools to amplify the immune response. The observation, however, that the ligand repertoire can be affected through polymorphic sites form the outside may also imply that environmental factors could induce allergic or autoimmune reactions in an allele-selective manner.


Received for publication, July 6, 2006

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{diamondsuit} This article was selected as a Paper of the week.

1 Supported by a grant awarded by a Ph.D. stipend program of the Max-Delbrück-Center.

2 Supported by the Marie-Curie Research Training Network "Drugs for Therapy" program.

3 These authors were all supported by the Federal Ministry of Education and Research-sponsored "MHCenhancer" network.

4 To whom correspondence may be addressed. Tel.: 49-30-9406-3664; Fax: 49-30-9406-2394; E-mail: falk{at}mdc-berlin.de. 5 To whom correspondence may be addressed. Tel.: 49-30-9406-3664; Fax: 49-30-9406-2394; E-mail: roetzsch{at}mdc-berlin.de.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. J. Call, X. Xing, G. D. Cuny, N. P. Seth, D. M. Altmann, L. Fugger, M. Krogsgaard, R. L. Stein, and K. W. Wucherpfennig
In Vivo Enhancement of Peptide Display by MHC Class II Molecules with Small Molecule Catalysts of Peptide Exchange
J. Immunol., May 15, 2009; 182(10): 6342 - 6352.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement